BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 29488773)

  • 1. [Curcumine (Turmeric - Curcuma longa) as a Supportive Phytotherapeutic Treatment in Oncology].
    Frassová Z; Rudá-Kučerová J
    Klin Onkol; 2017; 31(1):15-23. PubMed ID: 29488773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Milk Thistle (Silybum Marianum) as a Supportive Phytotherapeutic Agent in Oncology].
    Frassová Z; Rudá-Kučerová J
    Klin Onkol; 2017; 30(6):426-432. PubMed ID: 29271213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin content of turmeric and curry powders.
    Tayyem RF; Heath DD; Al-Delaimy WK; Rock CL
    Nutr Cancer; 2006; 55(2):126-31. PubMed ID: 17044766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
    Luthra PM; Lal N
    Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin: the Indian solid gold.
    Aggarwal BB; Sundaram C; Malani N; Ichikawa H
    Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
    Soleimani V; Sahebkar A; Hosseinzadeh H
    Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
    Bar-Sela G; Epelbaum R; Schaffer M
    Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.
    Razavi BM; Ghasemzadeh Rahbardar M; Hosseinzadeh H
    Phytother Res; 2021 Dec; 35(12):6489-6513. PubMed ID: 34312922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
    Bashang H; Tamma S
    Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turmeric and Curcumin: From Traditional to Modern Medicine.
    Akaberi M; Sahebkar A; Emami SA
    Adv Exp Med Biol; 2021; 1291():15-39. PubMed ID: 34331682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells.
    Lee HM; Patel V; Shyur LF; Lee WL
    Phytomedicine; 2016 Nov; 23(12):1535-1544. PubMed ID: 27765374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer potential of curcumin: preclinical and clinical studies.
    Aggarwal BB; Kumar A; Bharti AC
    Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review.
    Hosseini A; Hosseinzadeh H
    Biomed Pharmacother; 2018 Mar; 99():411-421. PubMed ID: 29367110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Daily JW; Yang M; Park S
    J Med Food; 2016 Aug; 19(8):717-29. PubMed ID: 27533649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
    Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
    Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin: therapeutical potential in ophthalmology.
    Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
    Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin (Turmeric) and cancer.
    Unlu A; Nayir E; Dogukan Kalenderoglu M; Kirca O; Ozdogan M
    J BUON; 2016; 21(5):1050-1060. PubMed ID: 27837604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
    Tyagi AK; Prasad S; Yuan W; Li S; Aggarwal BB
    Invest New Drugs; 2015 Dec; 33(6):1175-86. PubMed ID: 26521943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcriptomic analysis of turmeric: Curcumin represses the expression of cholesterol biosynthetic genes and synergizes with simvastatin.
    Einbond LS; Manservisi F; Wu HA; Balick M; Antonetti V; Vornoli A; Menghetti I; Belpoggi F; Redenti S; Roter A
    Pharmacol Res; 2018 Jun; 132():176-187. PubMed ID: 29408497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.